Synthesis of Fingolimod Employing Regioselective Aziridine Ring-Opening Reaction as a Key Step

被引:2
作者
Doubsky, Jan [1 ]
Radl, Stanislav [1 ]
Cinibulk, Josef [1 ]
Klvana, Robert [1 ,2 ]
机构
[1] Zentiva Ks, API Synth Dev, Prague 10237, Czech Republic
[2] Teva Czech Ind Sro, Ostravska 305-29, Opava 74770, Czech Republic
关键词
fingolimod; aziridine; regioselective ring opening; cross-coupling reaction; transition metal catalysis; EFFICIENT SYNTHESIS; ACTIVE CATALYST; ARYL CHLORIDES; PALLADIUM; DERIVATIVES; EPOXIDES; REAGENTS; METAL;
D O I
10.1021/acs.oprd.1c00248
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
An efficient and scalable synthesis of the immunomodulating drug fingolimod hydrochloride has been developed with the aziridine regioselective ring-opening reaction as a key step. This manuscript describes design, detailed synthetic route scouting, and optimization study of the aziridine ring-opening reaction. As a starting material for the polar part of the fingolimod molecule, cheap, common, and widely commercially available tris(hydroxymethyl)aminomethane was used. n-Octyl group was introduced into the molecule either via Kumada or Negishi cross-couplings, or alternatively by Sonogashira cross-coupling followed by hydrogenation. The final step consists of a one-pot acidic deprotection both of the acetonide and Boc group, providing thus highly pure fingolimod hydrochloride from the crude reaction mixture directly. The described process is highly effective, is industrially applicable, and has been successfully applied to 500 g scales of the target product.
引用
收藏
页码:859 / 878
页数:20
相关论文
共 50 条
  • [1] DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-SUBSTITUTED-2-AMINO-1,3-PROPANEDIOLS - DISCOVERY OF A NOVEL IMMUNOSUPPRESSANT, FTY720
    ADACHI, K
    KOHARA, T
    NAKAO, N
    ARITA, M
    CHIBA, K
    MISHINA, T
    SASAKI, S
    FUJITA, T
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) : 853 - 856
  • [2] Adachi K., 1998, Novel process for producing 2- amino- 2-(2-(4octylphenyl) ethyl) propane- 1,3-diol, Patent No. 11310556
  • [3] Adachi K, 2007, PERSPECT MED CHEM, V1, P11
  • [4] Fingolimod is a potential novel therapy for multiple sclerosis
    Aktas, Orhan
    Kuery, Patrick
    Kieseier, Bernd
    Hartung, Hans-Peter
    [J]. NATURE REVIEWS NEUROLOGY, 2010, 6 (07) : 373 - 382
  • [5] Use of (S)-N-tert-butoxycarbonylaziridine-2-carboxylate derivatives for alpha-amino acid synthesis
    Baldwin, JE
    Farthing, CN
    Russell, AT
    Schofield, CJ
    Spivey, AC
    [J]. TETRAHEDRON LETTERS, 1996, 37 (21) : 3761 - 3764
  • [6] Blagoev B., 1970, SYNTHESIS, V1970, P615
  • [7] QSAR guided synthesis of simplified antiplasmodial analogs of naphthylisoquinoline alkaloids
    Bringmann, Gerhard
    Bischof, Sebastian K.
    Mueller, Steffen
    Gulder, Tanja
    Winter, Christian
    Stich, August
    Moll, Heidrun
    Kaiser, Marcel
    Brun, Reto
    Dreher, Jan
    Baumann, Knut
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) : 5370 - 5383
  • [8] A convergent synthesis of the immunosuppressant FTY720 employing aqueous Wittig chemistry
    Calzavara, Janice
    McNulty, James
    [J]. TETRAHEDRON LETTERS, 2011, 52 (43) : 5672 - 5675
  • [9] A SIMPLE STRATEGY FOR THE SYNTHESIS OF HYDROXYETHYLENE DIPEPTIDE ISOSTERE FROM D-GLUCOSE
    CHAKRABORTY, TK
    HUSSAIN, KA
    THIPPESWAMY, D
    [J]. TETRAHEDRON, 1995, 51 (13) : 3873 - 3880
  • [10] The first general method for palladium-catalyzed Negishi cross-coupling of aryl and vinyl chlorides:: Use of commercially available Pd(P(t-BU)3)2 as a catalyst
    Dai, CY
    Fu, GC
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (12) : 2719 - 2724